Bigelow Investment Advisors LLC Sells 98 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Bigelow Investment Advisors LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,404 shares of the healthcare conglomerate’s stock after selling 98 shares during the quarter. UnitedHealth Group accounts for approximately 1.5% of Bigelow Investment Advisors LLC’s investment portfolio, making the stock its 13th largest holding. Bigelow Investment Advisors LLC’s holdings in UnitedHealth Group were worth $2,845,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in UNH. Kraft Davis & Associates LLC grew its stake in UnitedHealth Group by 3.4% in the third quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock valued at $294,000 after purchasing an additional 19 shares during the last quarter. Iron Horse Wealth Management LLC boosted its holdings in UnitedHealth Group by 1.6% in the third quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock worth $614,000 after acquiring an additional 19 shares in the last quarter. Secure Asset Management LLC boosted its holdings in UnitedHealth Group by 0.8% in the third quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock worth $1,238,000 after acquiring an additional 19 shares in the last quarter. Bensler LLC lifted its holdings in shares of UnitedHealth Group by 0.3% during the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock worth $3,677,000 after purchasing an additional 19 shares during the period. Finally, Texas Capital Bancshares Inc TX lifted its holdings in shares of UnitedHealth Group by 1.1% during the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock worth $855,000 after purchasing an additional 19 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. Deutsche Bank Aktiengesellschaft lifted their target price on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday. Bank of America reissued a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a report on Wednesday, April 10th. Piper Sandler boosted their price objective on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday. Finally, Truist Financial restated a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a research report on Wednesday. Four analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Stock Performance

Shares of UNH stock traded up $7.95 during midday trading on Friday, hitting $501.13. The company had a trading volume of 6,585,712 shares, compared to its average volume of 4,551,375. The company’s 50 day simple moving average is $488.97 and its 200 day simple moving average is $515.22. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The stock has a market cap of $462.01 billion, a price-to-earnings ratio of 30.63, a PEG ratio of 1.31 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period in the previous year, the business earned $6.26 earnings per share. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.74 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a yield of 1.50%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 45.97%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.